BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37066443)

  • 1. Infantile B-lymphoblastic leukemia: a case series and review of the literature.
    Mansoor N; Imran S; Maqsood S; Pasha S; Jabbar N
    J Int Med Res; 2023 Apr; 51(4):3000605231167789. PubMed ID: 37066443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
    Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.
    Sarashina T; Iwabuchi H; Miyagawa N; Sekimizu M; Yokosuka T; Fukuda K; Hamanoue S; Iwasaki F; Goto S; Shiomi M; Imai C; Goto H
    Int J Hematol; 2016 Jul; 104(1):139-43. PubMed ID: 27084248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Cryptic Rearrangements in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Involving the MLL Gene.
    Othman MA; Grygalewicz B; Pienkowska-Grela B; Rincic M; Rittscher K; Melo JB; Carreira IM; Meyer B; Marzena W; Liehr T
    J Histochem Cytochem; 2015 May; 63(5):384-90. PubMed ID: 25699572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
    Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN
    Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
    Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
    Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and genetic spectrum of infantile B-lymphoblastic leukemia: a multi-institutional study.
    Knez V; Liu X; Schowinsky J; Pan Z; Wang D; Lorsbach R; Lu C; Luedke C; Haag M; Carstens B; Swisshelm K; Yang LH; Jug R; Wang E; Liang X
    Leuk Lymphoma; 2019 Apr; 60(4):1006-1013. PubMed ID: 30188223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia].
    Shi Y; Lu Y; Zhang RD; Zhang YY; Lin W; Yu JJ; Wu Y; Fan J; Qi PJ; Huang PL; Cai LX; Huang Q; Zhang P; Sun YM; Liu Y; Zheng HY
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):49-54. PubMed ID: 38154977
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of various MLL gene aberrations that lead to MLL gene mutation in patients with acute lymphoblastic leukemia (ALL) and infants with acute leukemia.
    Pais A; Amare Kadam P; Raje G; Sawant M; Kabre S; Jain H; Advani S; Banavali S
    Leuk Res; 2005 May; 29(5):517-26. PubMed ID: 15755504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of lymphoblastic leukemia.
    Goud KI; Dayakar S; Prasad SV; Rao KN; Shaik A; Vanjakshi S
    J Cancer Res Ther; 2013; 9(3):493-6. PubMed ID: 24125990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical utility of fluorescence in-situ hybridization profile test in detecting genetic aberrations in acute leukemia].
    Kim SR; Kim HJ; Kim SH
    Korean J Lab Med; 2009 Oct; 29(5):371-8. PubMed ID: 19893343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic characterization of childhood acute lymphoblastic leukemia in Nicaragua.
    Ceppi F; Brown A; Betts DR; Niggli F; Popovic MB
    Pediatr Blood Cancer; 2009 Dec; 53(7):1238-41. PubMed ID: 19672974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
    Popov A; Tsaur G; Permikin Z; Henze G; Verzhbitskaya T; Plekhanova O; Nokhrina E; Valochnik A; Sibiryakov P; Zerkalenkova E; Olshanskaya Y; Gindina T; Movchan L; Shorikov E; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30204. PubMed ID: 36715125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid sarcoma concurrent with de novo KMT2A gene-rearranged infantile acute lymphoblastic leukemia.
    Abe H; Hamada S; Sakiyama H; Oshiro T; Kato M; Yagi T; Matsuda T; Higa T; Hyakuna N; Nakanishi K
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29573. PubMed ID: 35044058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.